To the full analysis
CareDx stock: growth
CDNACareDx reported $379.81M in revenue for fiscal 2025, up 13.8% on the prior year, up 14.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
25.2%
per year from 2012 to 2025, per share 7.5%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2012 | |
|---|---|---|---|
| Revenue | 14.6% | 29.7% | 25.2% |
| Revenue per share | 11.5% | 11.6% | 7.5% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | 9.4% | no data | no data |
| Free cash flow per share | 6.4% | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2012 | $20.45M | −$5.06M | −$1.92M |
| 2013 | $22.1M | −$3.54M | −$644K |
| 2014 | $27.31M | $781K | −$4.08M |
| 2015 | $28.14M | −$13.71M | −$10.95M |
| 2016 | $40.63M | −$39.47M | −$17.07M |
| 2017 | $48.32M | −$55.47M | −$14.49M |
| 2018 | $76.57M | −$46.76M | −$11.24M |
| 2019 | $127.07M | −$21.97M | −$6.12M |
| 2020 | $192.19M | −$18.71M | $23.07M |
| 2021 | $296.4M | −$30.66M | −$39.55M |
| 2022 | $321.79M | −$76.61M | −$49.57M |
| 2023 | $280.32M | −$190.28M | −$27.63M |
| 2024 | $333.79M | $52.55M | $31.56M |
| 2025 | $379.81M | −$21.35M | $36.12M |
Revenue by segment
How CareDx, Inc makes its money and how that has shifted. Names are as the company reports them.
- Service72%
- Product13%
- Other15%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2024 | 2025 | Share 2025 | |
|---|---|---|---|
| Service | $249.38M | $274.5M | 72.3% |
| Product | $40.78M | $48.38M | 12.7% |
| Other | $43.62M | $56.93M | 15% |
| Total revenue | $333.79M | $379.81M | 100% |
Revenue by region
Where CareDx, Inc generates its revenue.
- United States$359.9M95%
- Outside the US$19.9M5%
The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| United States | $359.94M | 94.8% |
| Outside the US | $19.87M | 5.2% |
| Total revenue | $379.81M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 24 Jul 2026)
- Valuation signal Overvalued since 8 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.